News

The FiberNet embolic protection system (EPS), which received the FDA clearance in November 2008, is indicated for the treatment of patients receiving endovascular intervention for carotid artery disease.

The complex human EGF receptor (HER) family of receptors and growth factor ligands is dysregulated in about half of all solid cancers. Receptor BioLogix’s pan-HER ligand traps are

Under the terms of the agreement, CPC Scientific will offer Sigma-Aldrich’s PEPscreen custom peptide libraries to life science researchers and pharmaceutical companies in North America. Sigma-Aldrich has developed

These trials are the first step toward the FDA clinical trials to test the efficacy of using International Stem Cell Corporation (ISCO) cells to improve healing after corneal

The commission has approved an agreement containing consent order that Getinge and Datascope entered into with the Federal Trade Commission (FTC) staff on January 15, 2009 and has

Pursuant to the terms of the agreement, Laiyang will purchase the majority of the assets owned by Hongrui, including all tangible assets, including without limitation, all manufacturing and

Mr Casdin is founder of Casdin Advisors where he serves as a strategic advisor to the life sciences industry. Mr Casdin holds an MBA from Columbia Business School,

The company posted net sales of $8.19 billion in the fourth quarter of 2008, a marginal increase, compared to $8.17 billion posted in the corresponding period of 2007.

Dr Sparks said: “Canyon Gate Medical Group holds a great vision for healthcare in Las Vegas. This new partnership will allow our patients to have one location for